MedTrace Logo

The ABSORB Bioresorbable Scaffold Below the Knee (BTK) Study

NCT02793349 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2019-04-17

No results posted yet for this study

Summary

ABSORB BTK Study: A prospective, multicenter, controlled clinical evaluation of the use of a bioresorbable drug eluting stent in the arterial vasculature below the knee

Conditions

  • Ischemia
  • Peripheral Arterial Disease (PTA
  • Arterial Occlusive Diseases

Interventions

DEVICE

Absorb Bioresorbable Vascular Scaffold

Absorb Bioresorbable Vascular Scaffold

Sponsors & Collaborators

  • The University of New South Wales

    lead OTHER

Principal Investigators

  • Ramon L Varcoe, MS,FRACS,PhD · Prince of Wales Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • Australia
  • Netherlands
  • New Zealand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02793349 on ClinicalTrials.gov